Improving methods to study the human microbiome
Statistical methods to enhance reproducible microbiome discovery
['FUNDING_OTHER'] · UNIVERSITY OF WASHINGTON · NIH-10839570
This study is working on making microbiome research more reliable so that scientists can better understand diseases like cancer and autoimmune disorders, by creating helpful tools and software that improve how they analyze tiny organisms in our bodies.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF WASHINGTON (nih funded) |
| Locations | 1 site (SEATTLE, UNITED STATES) |
| Trial ID | NIH-10839570 on ClinicalTrials.gov |
What this research studies
This research focuses on enhancing the reliability of microbiome studies, which are crucial for understanding various human diseases, including cancer and autoimmune disorders. It aims to develop statistical tools that help researchers accurately analyze microbial genetic sequences while addressing biases and variability that can affect results. By creating open-source software and providing guidance on experimental design, the project seeks to improve the quality and reproducibility of microbiome research, ultimately aiding in better diagnosis and treatment strategies for complex diseases.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals suffering from autoimmune diseases, cancers, or other disorders influenced by the microbiome.
Not a fit: Patients with conditions unrelated to microbiome health or those not involved in microbiome studies may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more accurate diagnoses and effective treatments for diseases linked to the microbiome.
How similar studies have performed: Previous research has shown that improving statistical methods in microbiome studies can lead to significant advancements in understanding disease mechanisms.
Where this research is happening
SEATTLE, UNITED STATES
- UNIVERSITY OF WASHINGTON — SEATTLE, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: WILLIS, AMY D — UNIVERSITY OF WASHINGTON
- Study coordinator: WILLIS, AMY D
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Autoimmune Diseases, Cancers, Disease, Disorder